• Stiripentol: LDH Inhibitor Innovations for Epilepsy & Metabo

  2026-07-06

  Stiripentol, a potent LDH inhibitor from APExBIO, enables researchers to dissect astrocyte-neuron lactate shuttle modulation and histone lactylation with precision. This article offers actionable protocols, troubleshooting strategies, and comparative insights for translational neuroscience and immunometabolic workflows.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Gene De

  2026-07-05

  1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) unlocks reliable and efficient nucleic acid delivery for both transient and stable gene expression. Explore experimental protocols, practical troubleshooting, and cutting-edge applications, including immunometabolic nanoparticle engineering, that set APExBIO's DOTAP apart for advanced biomedical workflows.

• Chlorpromazine HCl: Dopamine Antagonism in Neuropharmacology

  2026-07-04

  Chlorpromazine HCl is a benchmark dopamine receptor antagonist used in psychotic disorder research and cellular infection models. Its well-characterized mechanism enables precise modulation of neurological and immune pathways. New evidence positions it as a critical tool for both neuropharmacology and host-directed antibacterial studies.

• Naloxone Hydrochloride: Beyond Antagonism in Translational R

  2026-07-03

  This thought-leadership article explores how Naloxone hydrochloride, a potent opioid receptor antagonist, transcends its classical role in overdose intervention to empower translational breakthroughs in neural stem cell biology, immune modulation, and addiction research. Integrating mechanistic insights, protocol guidance, and competitive benchmarking, this piece provides actionable strategies for researchers seeking to leverage APExBIO’s high-purity Naloxone hydrochloride in next-generation experimental designs.

• ATS-9R: Targeted Non-Viral Gene Delivery to Adipocytes

  2026-07-03

  ATS-9R (Adipocyte-targeting sequence-9-arginine) enables precise, non-viral gene delivery to white adipose tissue via prohibitin-mediated endocytosis. This platform facilitates efficient gene silencing in adipocytes, supporting research into obesity, inflammation, and insulin resistance. Peer-reviewed evidence confirms its safety, specificity, and translational potential.

• ORAI2-Driven SOCE and Early Postirradiation Salivary Gland F

  2026-07-02

  This study identifies ORAI2-mediated store-operated calcium entry (SOCE) as a central driver of early-stage postirradiation fibrosis in salivary glands. By mapping the ORAI2/JNK/NFAT1/TGF-β1 axis and demonstrating that pharmacological SOCE inhibition mitigates fibrosis, it establishes a mechanistic framework for targeted intervention in radiation-induced salivary gland dysfunction.

• Viperin Targets nsp8 to Block Coronavirus Replication Comple

  2026-07-02

  Zhou et al. (2026) reveal that viperin inhibits a wide range of coronaviruses by directly binding non-structural protein 8 (nsp8), thereby disrupting replication-transcription complex (RTC) assembly and impeding RNA-dependent RNA polymerase (RdRp) activity. This work uncovers a conserved antiviral mechanism and highlights new opportunities for developing broad-spectrum RNA virus replication inhibitors.

• Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability & Cyto

  2026-07-01

  The Cell Counting Kit-8 (CCK-8) enables sensitive, quantitative cell viability measurement using WST-8 chemistry. Its water-soluble format provides superior ease of use compared to traditional tetrazolium-based assays. CCK-8 is a benchmark tool for cell proliferation and cytotoxicity assessment in modern biomedical research.

• Applied Workflows with the Alcian Blue & Nuclear Fast Red St

  2026-07-01

  The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 empowers researchers to robustly detect mucopolysaccharides and assess chondrogenic differentiation, all within a streamlined protocol that eliminates acetic acid pre-incubation. Discover real-world troubleshooting, experimental enhancements, and how this kit sets new standards for mucin detection in stem cell and tissue assays.

• Patient-Derived Organoids from Breast Adenomyoepithelioma: A

  2026-06-30

  This study reports the first successful establishment and characterization of three-dimensional organoids derived from a patient with adenomyoepithelioma (AME) of the breast. The model enables detailed investigation into AME biology and drug sensitivity, offering a robust platform for future research on this rare tumor.

• Protease Inhibitor Cocktail: Optimizing Protein Extraction W

  2026-06-30

  The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO delivers robust, broad-spectrum protection against protein degradation, enabling high-fidelity results in advanced oncology assays. This guide details optimized workflows, troubleshooting insights, and protocol parameters, drawing on the latest translational research to maximize reproducibility and data integrity.

• Smoothened Function in Honeybee Olfaction: Mechanisms and Mo

  2026-06-29

  This study provides the first in-depth analysis of Smoothened (Smo) expression and function in the olfactory system of Apis mellifera, showing that Smo activity modulates olfactory receptor expression and behavioral responses in honeybees. These findings establish a mechanistic link between Hedgehog pathway activation and insect sensory biology, offering new experimental avenues for functional analysis of Smo in invertebrate models.

• Chlorpromazine HCl: Mechanistic Leverage for Translational D

  2026-06-29

  This thought-leadership article explores the mechanistic depth and translational impact of Chlorpromazine HCl, a phenothiazine dopamine receptor antagonist, with a focus on actionable guidance for researchers bridging neuropharmacology and host-directed antibacterial strategies. Integrating recent peer-reviewed findings and APExBIO’s rigorous reagent characterization, the article positions Chlorpromazine HCl as a linchpin for innovation in both neurological and infection biology models, while providing protocol recommendations and a balanced outlook on cross-domain applications.

• Standardized Whole-Blood Immunometabolism Analysis Protocol

  2026-06-28

  This study introduces a rigorously standardized protocol for stimulating whole blood with defined metabolic interventions, enabling reproducible analysis of immune responses under metabolic modulation. The approach advances immunometabolism research by clarifying how metabolic pathways selectively regulate cytokine production in human samples.

• Promethazine HCl in Immunology: Workflow Optimizations & Ins

  2026-06-27

  Promethazine HCl is redefining immunology and inflammation research as a potent tool for activating macrophage antibacterial defenses through ROS and autophagy. This article unpacks experimental workflow advances, troubleshooting methods, and protocol enhancements to maximize reproducibility and data richness when leveraging this phenothiazine compound.

584 records 6/39 page Previous Next First page 上5页 678910 下5页 Last page